Literature DB >> 16158902

Immune reconstitution to Mycobacterium tuberculosis after discontinuing infliximab.

Robert Belknap, Randall Reves, William Burman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16158902

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN： 1027-3719            Impact factor:   2.373


× No keyword cloud information.
  12 in total

1.  [Immune reconstitution syndrome].

Authors:  D Meyer-Olson; D Ernst; M Stoll
Journal:  Z Rheumatol       Date:  2012-04       Impact factor: 1.372

2.  A Paradoxical Treatment for a Paradoxical Condition: Infliximab Use in Three Cases of Mycobacterial IRIS.

Authors:  Denise C Hsu; Kimberly F Faldetta; Luxin Pei; Virginia Sheikh; Netanya S Utay; Gregg Roby; Adam Rupert; Anthony S Fauci; Irini Sereti
Journal:  Clin Infect Dis       Date:  2015-09-22       Impact factor: 9.079

Review 3.  Infectious complications associated with monoclonal antibodies and related small molecules.

Authors:  Edsel Maurice T Salvana; Robert A Salata
Journal:  Clin Microbiol Rev       Date:  2009-04       Impact factor: 26.132

4.  Tuberculosis complicated by immune reconstitution inflammatory syndrome in a patient on anti-TNFα therapy for Crohn's disease.

Authors:  Caroline O'Dowd; Peter Kewin; John Morris; Mark Cotton
Journal:  BMJ Case Rep       Date:  2011-03-08

Review 5.  Immune reconstitution inflammatory syndrome: the trouble with immunity when you had none.

Authors:  Daniel L Barber; Bruno B Andrade; Irini Sereti; Alan Sher
Journal:  Nat Rev Microbiol       Date:  2012-01-09       Impact factor: 60.633

Review 6.  Immune reconstitution inflammatory syndrome associated with biologic therapy.

Authors:  Malika Gupta; Kashif Jafri; Rebecca Sharim; Susanna Silverman; Sayantani B Sindher; Anupama Shahane; Mildred Kwan
Journal:  Curr Allergy Asthma Rep       Date:  2015-02       Impact factor: 4.919

7.  Granulomatous hepatitis secondary to histoplasma infection after treatment with infliximab.

Authors:  L Barrera; J Alvarez; M Tapias; V Idrovo; R López
Journal:  Case Reports Hepatol       Date:  2013-12-14

8.  Paradoxical response during antituberculous therapy in a patient discontinuing infliximab: a case report.

Authors:  Young Kyung Yoon; Jeong Yeon Kim; Jang Wook Sohn; Min Ja Kim; Ja Seol Koo; Jai Hyun Choi; Dae Won Park
Journal:  J Med Case Rep       Date:  2009-04-01

Review 9.  Immune reconstitution inflammatory syndrome in HIV-infected patients receiving antiretroviral therapy : pathogenesis, clinical manifestations and management.

Authors:  Devesh J Dhasmana; Keertan Dheda; Pernille Ravn; Robert J Wilkinson; Graeme Meintjes
Journal:  Drugs       Date:  2008       Impact factor: 9.546

Review 10.  Crucial Role of Viral Reactivation in the Development of Severe Drug Eruptions: a Comprehensive Review.

Authors:  Tetsuo Shiohara; Yukiko Ushigome; Yoko Kano; Ryo Takahashi
Journal:  Clin Rev Allergy Immunol       Date:  2015-10       Impact factor: 10.817
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.